You have read all your free articles, to continue reading subscribe to read the rest of this content.
The two companies have agreed on a partnership for the Nordic and Baltic markets with the aim to support healthcare. One possible field of cooperation is the use of cutting-edge technique, such as artificial intelligence, to support early diagnosis for i.a. lung cancer, they state. "The Nordic anAlready a subscriber…
Orion Corporation and Phyxius Pharma have entered into a licensing agreement for levosimendan injection. According to the agreement Phyxius Pharma will develop and commercialize levosimendan in the USA and Canada for a new cardiovascular indication, prevention of Low Cardiac Output Syndrome (LCOS) iAlready a subscriber Login You have read all…
The aim is to identify development opportunities both with Ygalo within the planned first indication, new indications and for the further development of Oncopeptides' pipeline. Professor Paul G. Richardson, MD, will be chairman of this clinical advisory board. The other members are Dr. Lori A KunAlready a subscriber Login You…
Imfinzi has been approved in the US for the treatment of adult patients with locally advanced or metastatic biliary tract cancer (BTC) in combination with chemotherapy (gemcitabine plus cisplatin). The approval by the Food and Drug Administration (FDA) was based on the results from the TOPAZ-1 PhAlready a subscriber Login…
